YU45793B - Postupak za dobijanje stabilnih kristalnih adicionih soli 7-/alfa-(2-aminotiazola-4-il)-alfa-(z)-metoksiimino acetamido/-3-/(1-metil-1-pirolidino)-metil/-3-cefem-karboksilata sa kiselinama, kao i preparata koji ih sadrže - Google Patents

Postupak za dobijanje stabilnih kristalnih adicionih soli 7-/alfa-(2-aminotiazola-4-il)-alfa-(z)-metoksiimino acetamido/-3-/(1-metil-1-pirolidino)-metil/-3-cefem-karboksilata sa kiselinama, kao i preparata koji ih sadrže

Info

Publication number
YU45793B
YU45793B YU137186A YU137186A YU45793B YU 45793 B YU45793 B YU 45793B YU 137186 A YU137186 A YU 137186A YU 137186 A YU137186 A YU 137186A YU 45793 B YU45793 B YU 45793B
Authority
YU
Yugoslavia
Prior art keywords
alpha
methyl
aminothiazola
pyrolidino
cefem
Prior art date
Application number
YU137186A
Other languages
English (en)
Other versions
YU137186A (en
Inventor
M.A. Kaplan
T.W. Hudyma
R.A. Lipper
Original Assignee
Bristol-Myers Squibb Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol-Myers Squibb Company filed Critical Bristol-Myers Squibb Company
Publication of YU137186A publication Critical patent/YU137186A/xx
Publication of YU45793B publication Critical patent/YU45793B/sh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/38—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof
    • C07D501/46—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof with the 7-amino radical acylated by carboxylic acids containing hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

POSTUPAK ZA DOBIJANJE STABILNIH KRISTALNIH ADICIONIH SOLI 7-/ALFA-(2-AMINOTIAZOLA-4-IL)-ALFA-(Z)-METOKSIIMINO ACETAMIDO/-3-/(1-METIL-1-PIROLIDINO)-METIL/-3-CEFEM-KARBOKSILATA SA KISELINAMA, KAO I PREPARATA KOJI IH SADRŽE , naznačen time, što se gradi smeša bar dva molska ekvivalenta azotne kiseline i amfoternog jona koji odgovara navedenoj adicionoj soli sa kiselinom, tako da njegova koncentracija u smeši bude veća od 100 mg/ml; što se kristalizacija navedene adicione soli sa kiselinom izaziva zasejavanjem ili trljanjem sa staklenim štapićem,, nakon čega sledi razblaživanje sa 2-propanolom i hladjenje; i što se vrši izolovanje stabilne kristalne dinitratne adicione soli sa kiselinom, poželjno filtriranjem, ispiranjem i sušenjem pod vakuumom. Prijava sadrži još 4 patentna zahteva.
YU137186A 1985-08-05 1986-07-31 Postupak za dobijanje stabilnih kristalnih adicionih soli 7-/alfa-(2-aminotiazola-4-il)-alfa-(z)-metoksiimino acetamido/-3-/(1-metil-1-pirolidino)-metil/-3-cefem-karboksilata sa kiselinama, kao i preparata koji ih sadrže YU45793B (sh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US76223585A 1985-08-05 1985-08-05

Publications (2)

Publication Number Publication Date
YU137186A YU137186A (en) 1987-12-31
YU45793B true YU45793B (sh) 1992-07-20

Family

ID=25064475

Family Applications (1)

Application Number Title Priority Date Filing Date
YU137186A YU45793B (sh) 1985-08-05 1986-07-31 Postupak za dobijanje stabilnih kristalnih adicionih soli 7-/alfa-(2-aminotiazola-4-il)-alfa-(z)-metoksiimino acetamido/-3-/(1-metil-1-pirolidino)-metil/-3-cefem-karboksilata sa kiselinama, kao i preparata koji ih sadrže

Country Status (34)

Country Link
JP (1) JPH0615548B2 (sh)
KR (1) KR930003121B1 (sh)
AR (1) AR243894A1 (sh)
AT (1) AT390957B (sh)
AU (1) AU597262B2 (sh)
BE (1) BE905219A (sh)
CA (1) CA1284994C (sh)
CH (1) CH675581A5 (sh)
CS (2) CS276717B6 (sh)
CY (1) CY1614A (sh)
DD (2) DD254941A5 (sh)
DE (1) DE3626375A1 (sh)
DK (1) DK162053C (sh)
EG (1) EG18003A (sh)
ES (1) ES2002112A6 (sh)
FI (1) FI84484C (sh)
FR (1) FR2585705B1 (sh)
GB (1) GB2179936B (sh)
GR (1) GR862055B (sh)
HK (1) HK99691A (sh)
HU (1) HU196602B (sh)
IE (1) IE59222B1 (sh)
IL (1) IL79608A (sh)
IT (1) IT1197067B (sh)
LU (2) LU88574I2 (sh)
MY (1) MY102212A (sh)
NL (1) NL8601991A (sh)
OA (1) OA08672A (sh)
PT (1) PT83134B (sh)
SE (1) SE469633B (sh)
SG (1) SG79791G (sh)
SU (1) SU1516013A3 (sh)
YU (1) YU45793B (sh)
ZA (1) ZA865842B (sh)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4883868A (en) * 1984-12-27 1989-11-28 Banyu Pharmaceutical Co., Ltd. 7-amino-3-(substituted isoindolinium)methyl-3-cephem derivatives
US4959469A (en) * 1984-12-27 1990-09-25 Banyu Pharmaceutical Company, Ltd. Crystalline cephalosporin compounds
US4910301A (en) * 1985-08-05 1990-03-20 Bristol-Myers Company Cefepime cephalosporin salts
US5244891A (en) * 1985-08-05 1993-09-14 Bristol-Myers Squibb Company Injectable compositions of cefepime dihydrochloride hydrate
US4808617A (en) * 1985-12-18 1989-02-28 Bristol-Myers Company Lyophilized or precipitated cephalosporin zwitterion and salt combination
KR950010084B1 (ko) * 1987-06-25 1995-09-06 반유세이야꾸 가부시끼가이샤 결정성 세팔로스포린 화합물, 그의 제조법 및 그의 제조 중간체
JPH02101081A (ja) * 1988-10-08 1990-04-12 Meiji Seika Kaisha Ltd セファロスポリン誘導体結晶性二塩酸塩及びその製造法
CA2011116C (en) * 1989-03-06 1999-11-16 Murray A. Kaplan Lyophilized bmy-28142 dihydrochloride for parenteral use
CA2101571A1 (en) * 1992-09-08 1994-03-09 Elizabeth A. Garofalo Crystalline dihydrate of a cephalosporin dihydrate salt and injectable compositions thereof
DE69427469T2 (de) * 1993-03-12 2001-10-31 Pharmacia & Upjohn Co., Kalamazoo Kristallines ceftiofur (freie säure)
EP0638573A1 (en) * 1993-08-10 1995-02-15 Lucky Ltd. Crystalline hydrates of cephalosporin and process for preparation thereof
WO2005063772A1 (en) 2003-12-23 2005-07-14 Sandoz Ag Process for production of intermediates for use in cefalosporin synthesis
WO2008056221A2 (en) * 2006-11-06 2008-05-15 Orchid Chemicals & Pharmaceuticals Limited Crystalline sulfate salt of cephalosporin antibiotic
DE102012101680A1 (de) * 2012-02-29 2013-08-29 Aicuris Gmbh & Co. Kg Pharmazeutische Zubereitung enthaltend ein antiviral wirksames Dihydrochinazolinderivat

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS55151588A (en) * 1979-05-14 1980-11-26 Takeda Chem Ind Ltd Preparation of cephalosporin salt crystal
US4406899A (en) * 1982-03-04 1983-09-27 Bristol-Myers Company Cephalosporins
CA1213882A (en) * 1982-03-04 1986-11-12 Jun Okumura Cephalosporins
US4525473A (en) * 1983-03-30 1985-06-25 Bristol-Myers Company Cephalosporins
DE3419015A1 (de) * 1984-05-22 1985-11-28 Bayer Ag, 5090 Leverkusen Verfahren zur herstellung von cephalosporinen
GB8424692D0 (en) * 1984-10-01 1984-11-07 Glaxo Group Ltd Chemical compounds
GB2165245B (en) * 1984-10-01 1988-05-25 Glaxo Group Ltd Chemical compounds

Also Published As

Publication number Publication date
YU137186A (en) 1987-12-31
ATA211086A (de) 1990-01-15
DK371886A (da) 1987-02-06
SU1516013A3 (ru) 1989-10-15
HK99691A (en) 1991-12-13
CH675581A5 (sh) 1990-10-15
HUT41802A (en) 1987-05-28
OA08672A (en) 1989-03-31
JPH0615548B2 (ja) 1994-03-02
KR880002530A (ko) 1988-05-09
DK162053C (da) 1992-02-10
AT390957B (de) 1990-07-25
FI84484C (fi) 1991-12-10
HU196602B (en) 1988-12-28
IT1197067B (it) 1988-11-25
FR2585705A1 (fr) 1987-02-06
IL79608A (en) 1991-07-18
FI84484B (fi) 1991-08-30
GR862055B (en) 1986-12-24
NL8601991A (nl) 1987-03-02
SE469633B (sv) 1993-08-09
DK162053B (da) 1991-09-09
ZA865842B (en) 1987-04-29
PT83134B (pt) 1989-07-31
IT8621409A1 (it) 1988-02-04
SG79791G (en) 1991-11-15
LU88574I2 (fr) 1995-03-01
EG18003A (en) 1991-08-30
GB2179936B (en) 1989-04-26
ES2002112A6 (es) 1988-07-16
SE8603308D0 (sv) 1986-08-04
AR243894A1 (es) 1993-09-30
AU6069486A (en) 1987-02-12
CS276717B6 (en) 1992-08-12
IL79608A0 (en) 1986-11-30
KR930003121B1 (ko) 1993-04-19
SE8603308L (sv) 1987-02-06
BE905219A (fr) 1987-02-04
DK371886D0 (da) 1986-08-04
IE59222B1 (en) 1994-01-26
AU597262B2 (en) 1990-05-31
MY102212A (en) 1992-05-15
LU86540A1 (fr) 1987-03-06
DE3626375A1 (de) 1987-02-12
GB8618989D0 (en) 1986-09-17
GB2179936A (en) 1987-03-18
CY1614A (en) 1992-07-10
DD254941A5 (de) 1988-03-16
DD268395A5 (de) 1989-05-31
IT8621409A0 (it) 1986-08-04
PT83134A (en) 1986-09-01
FR2585705B1 (fr) 1989-01-13
CA1284994C (en) 1991-06-18
CS276849B6 (en) 1992-08-12
JPS62103090A (ja) 1987-05-13
IE862078L (en) 1987-02-05
FI863155A0 (fi) 1986-08-01
FI863155A7 (fi) 1987-02-06

Similar Documents

Publication Publication Date Title
YU45793B (sh) Postupak za dobijanje stabilnih kristalnih adicionih soli 7-/alfa-(2-aminotiazola-4-il)-alfa-(z)-metoksiimino acetamido/-3-/(1-metil-1-pirolidino)-metil/-3-cefem-karboksilata sa kiselinama, kao i preparata koji ih sadrže
DE3752361D1 (de) Optisch aktive Pteridinderivate
ES2012948A6 (es) Procedimiento para la preparacion de sales de cefalosporina y composiciones inyectables
JPS54132592A (en) 3,7-di-substituted-3-cephem-4-carboxylic acid derivative, its salt, and their preparation
HUT59832A (en) Process for producing pharmaceutical compositions containing calcitonin
DK504384A (da) Stabil, vandig syreoploesning af cis-platin, egnet til injektion
NO132692B (sh)
CA2070882A1 (en) A process for large-scale production of antimicrobial peptide in high purity
NO175861C (no) Fremgangsmåte for fremstilling av vann-fri krystallinsk laktulose
DE69419037D1 (de) Feste aminoxid-maleinsäure-salze enthaltende zusammensetzungen
DE69505389D1 (de) Rückgewinnung einer carbonsäure aus einer ein amin und ein extraktionsanreicherungsmittel enthaltenden lösung
ES2132872T3 (es) Procedimiento de purificacion de diacetilreina.
KR870000237B1 (ko) 세라펩타제를 안정화 시키는 방법
PT93991A (pt) Processo para a preparacao de solucoes estaveis de analogos de rebecamicina
CA1128862A (en) Cephradine compositions and method
ES8205752A1 (es) Procedimiento para transformar la estructura de insulina quecristaliza de forma romboedrica
TNSN91036A1 (fr) 3'-deamino-4' deoxy-4'-amino-8-fluoro-anthracyclines et leur procede de fabrication
US3636201A (en) Accelerating the lysis of blood clots with urokinase and n-glycylpyrrolidine or salt thereof
Moriyama Studies on X-Agent VII. Time-Fluctuation of X-Agent
SU1586132A1 (ru) Способ получения тетрахлорпиколиновой кислоты
MY116452A (en) Cephalosporin salts and injectable compositions
BE874622A (fr) Nouveaux derives d'acide 7-(amino(1,3-dihydrobenzo (c) thienyl) acetamido)-cephalosporanique, utiles notamment comme antibiotiques, et leur procede de preparation
Moriyama Studies on X-agent
JPS5686139A (en) P-hydroxyphenylglycine o-toluenesulfonate
SU1640920A1 (ru) Способ очистки цис-диамминдихлорплатины (ii)